This site is intended for US healthcare professionals only

MyNovocure^® Support Program

In 4 steps, MyNovocure^® helps you easily integrate Optune Lua^® into your practice

Click on these 4 steps to help you integrate Optune Lua into your practice

DISCUSS treatment plan with multidisciplinary team, patient, and care partner

A coordinated approach with your multidisciplinary team is key for ensuring consistent communication with patients and care partners.

Present Optune Lua in a way that addresses your patient’s needs and concerns.

Remind patients and care partners about the support available to them through MyNovocure®.

Reinforce the treatment plan at subsequent visits.

DISCUSS

SUBMIT

FOLLOW-UP

MANAGE

Contact MyNovocure^® for all your practice and patient support needs

Call us any time of day:

+1-855-281-9301 (toll-free)

Or email us:

support@mynovocure.com

Next: FAQs

Important Safety Information

Contraindications

Do not use Optune Lua in patients with implantable electronic medical devices such as pacemakers or implantable automatic defibrillators, etc. Use of Optune Lua together with implanted electronic devices has not been tested and may lead to malfunctioning of the implanted device.

Do not use Optune Lua in patients known to be sensitive to conductive hydrogels. Skin contact with the gel used with Optune Lua may commonly cause increased redness and itching, and may rarely lead to severe allergic reactions such as shock and respiratory failure.

Warnings and Precautions

Optune Lua can only be prescribed by a healthcare provider that has completed the required certification training provided by Novocure^®.

The most common (≥10%) adverse events involving Optune Lua in combination with chemotherapy were anemia, constipation, nausea, asthenia, chest pain, fatigue, medical device site reaction, pruritus, and cough.

Other potential adverse effects associated with the use of Optune Lua include: treatment related skin toxicity, allergic reaction to the plaster or to the gel, electrode overheating leading to pain and/or local skin burns, infections at sites of electrode contact with the skin, local warmth and tingling sensation beneath the electrodes, muscle twitching, medical device site reaction and skin breakdown/skin ulcer.

If the patient has an underlying serious skin condition on the chest, evaluate whether this may prevent or temporarily interfere with Optune Lua treatment.

Do not prescribe Optune Lua for patients that are pregnant, you think might be pregnant or are trying to get pregnant, as the safety and effectiveness of Optune Lua in these populations have not been established.

Please click here to see Optune Lua Instructions For Use (IFU) for complete information regarding the device's indications, contraindications, warnings, and precautions.

MyNovocure® Support Program

In 4 steps, MyNovocure® helps you easily integrate Optune Lua® into your practice